Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Summary

Multi-center, prospective, randomized controlled clinical trial that will compare two treatment methods (PGA with TOOKAD® VTP and Active Surveillance) for treating localized prostate cancer. The study will include criteria for evaluation, biopsy, eligibility, informed consent, subsequent management and decision making conducted based on data provided locally at each center that follow a set of standardized criteria.

Timeline

Start

2020-03-31

Primary completion

2030-03-31

Completion

2030-07-01

Outcome

Outcome not reported

Stopped: “FDA didn't approve the design of the protocol so we didn't start the study”

Drugs

Indications